Sdi Limited · ASX:SDI

Sdi — Investor Presentation (August 2020)

19 slides from Sdi's investor presentation, Aug 21, 2020

  1. Slide 1: FY20 Results Presentation

    FY20 RESULTS PRESENTATION 21 August 2020 Samantha Cheetham CEO John Slaviero CFO/COO

  2. Slide 2: Your Smile. Our Vision.

    YOUR SMILE. OUR VISION. Long successful operating SDI conducts research and SDI sells to 100+ countries history – founded in 1972 development of specialist on all continents and with and listed on ASX in 1985 dentist materials undertaking sales teams and distribution and Australia’s largest the deve

  3. Slide 3: Agenda

    AGENDA o FY20 summary o Product categories o Key geographies o Financial performance o Strategy and Outlook

  4. Slide 4: FY20 Summary

    FY20 SUMMARY GROWTH MOMENTUM IMPACTED BY COVID-19 IN 2H20 Sales ($m) EBITDA ($M) 79.6 14.2 74.1 74.5 12.5 12.1 67.4 7.8 42.5 39.7 40.9 7.6 8.6 9.8 27.4 2.7 40.0 6.4 7.1 34.4 33.6 37.1 4.9 3.6 FY17 FY18 FY19 FY20 FY17 FY18 FY19 FY20 H1 ($m) H2 ($m) H1 ($m) H2 ($m) o Total Sales down 15.4% to $67.4m w

  5. Slide 5: Product Categories

    PRODUCT CATEGORIES \ \ ‘ i f =

  6. Slide 6: Category Overview

    CATEGORY OVERVIEW MOMENTUM IMPACTED BY COVID-19 WITH PRODUCTS TRENDS CONTINUING Aesthetics Whitening o Global government restrictions led to a decreased demand across all product groups, as globally most dentists were limited to emergency procedures only o Growth momentum achieved during the record

  7. Slide 7: Product Mix

    PRODUCT MIX STRATEGY ON TRACK; AESTHETICS AND WHITENING - 73% OF SALES Product Mix (% of sales) o Despite lower sales, strategy is on track with 19.6 higher margin Aesthetics and Whitening 33.1 29.9 26.1 23.0 marginally increased as a % of total sales 39.0 7.6 8.6 8.3 7.6 o These two categories now

  8. Slide 8: Key Geographies

    KEY GEOGRAPHIES ‘, rt rr

  9. Slide 9: Sales by Business Unit

    SALES BY BUSINESS UNIT Growth in local Growth in AUD Total AUD o Brazilian sales grew by 16.0% in local Sales by Business Unit currency, when adjusted for export sales currency % % Sales % previously exported from Australia, sales in Australian sales (including local currencies increased by 6.1% and

  10. Slide 10: Geographies

    GEOGRAPHIES Sales by geography (A$m) 27.6 23.7 19.2 Europe North America $23.7m (14.0%) 14.7 14.2 14.6 $14.6m (23.9%) Middle East/Africa 8.7 9.4 $6.9m (20.7%) 8.0 6.9 South America $8.0m (14.3%) APAC $14.2m (3.7%) APAC Middle South North Europe East / America America Africa FY19 FY20 10

  11. Slide 11: Financial Performance

    FINANCIAL PERFORMANCE Vv10d

  12. Slide 12: Profit & Loss

    PROFIT & LOSS Profit & Loss (#039;000) FY20 FY19 % Change o Total sales of $67.4 million, down 15.4% vs Revenue $79.6m in FY19, reflecting the challenges faced Sales Revenue 67,374 79,598 (15.4%) in the final quarter of the year Cost of goods sold (23,737) (29,805) (20.4%) Gross Profit 43,637 49,793 (1

  13. Slide 13: Balance Sheet

    BALANCE SHEET Balance Sheet (#039;000) FY20 FY19 o Net cash position decreased by $1.8 million Assets Cash & cash equivalents 6,153 6,481 o Reduction in receivables due to tight control of Trade & other receivables 9,605 17,780 outstanding invoices and lower total sales Inventories 20,656 17,242 o Inve

  14. Slide 14: Cash Flow

    CASH FLOW Cash Flow (#039;000) FY20 FY19 o Decrease in cash primarily due to lower Q4 sales Receipts from customers 75,146 78,215 & the inventory build up for Q4, which is typically Payments to suppliers & employees (66,154) (65,722) the strongest quarter for business Other revenue 1,121 72 Interest &

  15. Slide 15: Strategy & Outlook

    STRATEGY & OUTLOOK

  16. Slide 16: Strategy

    STRATEGY o Portfolio rationalisation complete with a 45% reduction of SKUs expected to drive further efficiencies o Aesthetics and Whitening products continue to be the focus o On-going investment in R&D to release 1-2 products per year is on target o SDI’s Amalgam replacement product is on schedule

  17. Slide 17: Outlook

    OUTLOOK o While outlook remains uncertain, FY21 expected to follow similar trends to previous years with growth in both the Aesthetic and Whitening products, and the continued decline in Amalgam products o Equipment sales are expected to grow with the roll out to all markets of the new curing light

  18. Slide 18: VV VI yey Vivi Vii Vip

    VV VI yey Vivi Vii Vip D1 | AURA Nala

  19. Slide 19: Disclaimer

    Disclaimer This Presentation contains summary information about SDI Limited (SDI) and its subsidiaries and their activities. The information in this Presentation does not purport to be complete. It should be read in conjunction with SDI’s other periodic and continuous disclosure announcements lodged

SDI — Investor Presentation (August 2020) on 6ix